Market Access Strategies for the Global Healthcare Environment mktxs linkedin 1-908-864-4090
ISPOR Amsterdam

As we gear up for an exciting final quarter of 2016, our  team prepares for a showcase of the work we’ve done throughout the year. This year we will be displaying fourteen research posters at the ISPOR 19th Annual European Congress in the Austria, 29 October – 2 November, 2016. Our research spans across a wide array of areas, encompassing respiratory, oncology, rare diseases, evidence and/or HTA landscapes, across more than 40 countries.

Check out our posters or stop by booth #311 to meet members of our team and learn about our latest research. Feel free to contact us with any questions or to discuss the research topics. We would love to hear your comments!

Poster Session II: Monday, October 31

Poster Display Hours: 15:45 – 19:45

Poster Author Discussion Hour: 18:45 – 19:45

PHP5 (A5): Use of internet and reliability of information obtained online concerning medication risks/safety: perceptions of conusmers in the U.S.

PHP7 (A7): Medication safety warnings: awareness, source, and actions of consumers int he U.S.

PHP8 (A8): Consumer perception of communication with healthcare professionals (HCPs) and information clarity concerning newly prescribed medication

PHP9 (A9): Poster award finalist - Reciept and delivery of medication risk and safety information: perceptions of consumers and healthcare professionals (HCPs) int he U.S.

PHP134 (D18): Poster award finalist - Use of electronic health information systems (EHIS) by healthcare professionals (HCPs) and the perception of its value in reducing medication risks and safety for patients

PHP276 (H5): Understanding Health Technology Assessment (HTA) bodies in major European markets: Systematic evaluation in 10 EU countries

PHP293 (H22): Understanding Health Technology Assessment (HTA) bodies in major Latin-American (LatAm) markets: Systematic evaluation in 5 LatAm countries

PHP301 (H30): Health Technology Assessment (HTA) bodies in major AsiaPacific (APAC) markets: Systematic evaluation in 10 APAC countries

 

Poster Session III: Tuesday, November 1

Poster Display Hours: 08:45 – 13:45

Poster Author Discussion Hour: 12:45 – 13:45

PSY154 (L21): Provisions and special considerations for rare diseases / orphan drugs by health technology assessment (HTA) bodies: systematic evaluation in 25 countries

PRS7 (E1): Systematic Literature Review to assess prevalence of GINA-defined segments of asthma and phenotypes

 

Poster Session V: Wednesday, November 2

Poster Display Hours: 08:45 – 13:45

Poster Author Discussion Hour: 12:45 – 13:45

PCN285 (K30): Trends in research using observational methodologies in chronic lymphocytic leukemia (CLL): A systematic literature review

PCN106 (G5): Economic burden associated with chronic myeloid leukemia (CML) treatments in the United States: A systematic literature review

PCN292 (K37): Special considerations and patient access schemes for oncology by health technology assessment (HTA) bodies: Systematic evaluation in 25 countries

PCN281 (K26): Combination Oncologics: A Boon or Burden to Healthcare Systems?